Frank Joseph Daugherty's most recent trade in Greenwich LifeSciences Inc was a trade of 104,890 Stock Options done . Disclosure was reported to the exchange on Dec. 24, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Greenwich LifeSciences Inc | Frank Daugherty Joseph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 104,890 | 209,780 | - | - | Stock Options | |
Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,890 | 104,890 | - | - | Stock Options | |
Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 16.25 per share. | 25 Apr 2022 | 1,000 | 90,121 | - | 16.3 | 16,250 | Common Stock |
Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 19.99 per share. | 13 Jan 2022 | 1,000 | 89,121 | - | 20.0 | 19,990 | Common Stock |
Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 26.99 per share. | 14 Dec 2021 | 1,111 | 88,121 | - | 27.0 | 29,983 | Common Stock |
Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 23 Nov 2020 | 1,000 | 87,010 | - | 5.1 | 5,100 | Common Stock |
Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 1,739 | 86,010 | - | 5.7 | 9,999 | Common Stock |